Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum Toxin and Occlusal Splint in Myofascial Pain Syndrome
NCT07082972Phase 4Recruiting
- Sponsor
- Istanbul University
- Start
- Sep 2025
- Primary completion
- Sep 2026
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of botulinum toxin type A in myofascial pain syndrome (MPS), sponsored by Istanbul University. Started Sep 2025; status: recruiting.
02
Drugs
botulinum toxin type A
03
Conditions
myofascial pain syndrome (MPS)
Beyond the preview
Go deeper on NCT07082972.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07082972.